BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6478056)

  • 1. Inhibition of lipid peroxidation in muscle homogenates by phospholipase A2 inhibitors.
    Jackson MJ; Jones DA; Harris EJ
    Biosci Rep; 1984 Jul; 4(7):581-7. PubMed ID: 6478056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phospholipase A2 inhibitors on diethyl maleate-induced lipid peroxidation and cellular injury in isolated rat hepatocytes.
    Stacey NH; Klaassen CD
    J Toxicol Environ Health; 1982 Mar; 9(3):439-50. PubMed ID: 6284950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of local anaesthetics on phospholipases.
    Kunze H; Nahas N; Traynor JR; Wurl M
    Biochim Biophys Acta; 1976 Jul; 441(1):93-102. PubMed ID: 952985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine.
    Filippov A; Skatova G; Porotikov V; Kobrinsky E; Saxon M
    Gen Physiol Biophys; 1989 Apr; 8(2):113-8. PubMed ID: 2777057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of agonist-induced degradation of muscarinic cholinergic receptor by quinacrine and tetracaine--possible involvement of phospholipase A2 in receptor degradation.
    Higuchi H; Uchida S; Matsumoto K; Yoshida H
    Eur J Pharmacol; 1983 Oct; 94(3-4):229-39. PubMed ID: 6653661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of non-steroidal inhibitors of phospholipase A2 on leukotriene and histamine release from human and guinea-pig lung.
    Kench JG; Seale JP; Temple DM; Tennant C
    Prostaglandins; 1985 Aug; 30(2):199-208. PubMed ID: 2413502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of insulin release due to inhibition of phospholipase A2 activity.
    Tanaka N; Kagawa S; Murakoso K; Shimizu S; Matsuoka A
    Horm Metab Res; 1983 May; 15(5):255-6. PubMed ID: 6409772
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of phospholipase A2 in calcium-induced damage in cardiac and skeletal muscle.
    Duncan CJ
    Cell Tissue Res; 1988 Aug; 253(2):457-62. PubMed ID: 3136926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor.
    Nakadate T; Yamamoto S; Ishii M; Kato R
    Cancer Res; 1982 Jul; 42(7):2841-5. PubMed ID: 6805948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of phospholipase A activity in rat liver microsomal lipid peroxidation.
    Beckman JK; Borowitz SM; Burr IM
    J Biol Chem; 1987 Feb; 262(4):1479-84. PubMed ID: 3805035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipase A2 inhibitors. Differential inhibition of fatty acid acylation into kidney lipids by mepacrine and p-bromophenacyl bromide.
    Erman A; Azuri R; Raz A
    Biochem Pharmacol; 1983 Jul; 32(13):2083-7. PubMed ID: 6870935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of enzymic and non-enzymic lipid peroxidation of flounder muscle sarcoplasmic reticulum by pretreatment with phospholipase A2.
    Shewfelt RL; Hultin HO
    Biochim Biophys Acta; 1983 May; 751(3):432-8. PubMed ID: 6849952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of phospholipase A2 in microsomal lipid peroxidation induced with t-butyl hydroperoxide.
    Borowitz SM; Montgomery C
    Biochem Biophys Res Commun; 1989 Feb; 158(3):1021-8. PubMed ID: 2920033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory and platelet anti-aggregant activity of phospholipase-A2 inhibitors.
    Vallee E; Gougat J; Navarro J; Delahayes JF
    J Pharm Pharmacol; 1979 Sep; 31(9):588-92. PubMed ID: 41058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of phospholipase A2 and glutathione peroxidase on the elimination of membrane lipid peroxides.
    Sevanian A; Muakkassah-Kelly SF; Montestruque S
    Arch Biochem Biophys; 1983 Jun; 223(2):441-52. PubMed ID: 6859870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of polymorphonuclear leucocyte phospholipase A2 activity by chloroquine and mepacrine.
    Authi KS; Traynor JR
    J Pharm Pharmacol; 1982 Nov; 34(11):736-8. PubMed ID: 6129307
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inhibition of phospholipid hydrolysis by phospholipase A2 in microsomal and mitochondrial membranes subjected to lipid peroxidation].
    Balevska PS; Kassabova EM; Rusanov EM; Kagan VE
    Biull Eksp Biol Med; 1985 Feb; 99(2):161-4. PubMed ID: 3971034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene and mepacrine antagonize the hemolysis of human red blood cells by halothane and bee venom phospholipase A2.
    Fletcher JE; Kistler P; Rosenberg H; Michaux K
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):410-9. PubMed ID: 3660410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of dog kidney Na+, K+-ATPase activity by procaine, tetracaine and dibucaine.
    Hudgins PM; Bond GH
    Biochem Pharmacol; 1984 Jun; 33(11):1789-96. PubMed ID: 6145421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local anesthetic inhibition of pancreatic phospholipase A2 action on lecithin monolayers.
    Hendrickson HS; van Dam-Mieras MC
    J Lipid Res; 1976 Jul; 17(4):399-405. PubMed ID: 133195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.